about the author

Brittany Meiling

editors@endpointsnews.com
Brittany Meiling on LinkedIn

author articles

Ex-FDA com­mish Califf joins Cy­to­ki­net­ics’ board just months af­ter big ALS flop

8 years ago
People

Cel­gene prices $4.5B se­nior notes to help buy Juno; Health Af­fairs study says No­var­tis prices its CAR-T too high

8 years ago
News Briefing

Al­ler­gan snatch­es Aus­tralian aes­thet­ics com­pa­ny Elasta­gen for $95M

8 years ago
Deals

Mar­ket crash slumps biotech as in­vestors yank $1.2B from funds

8 years ago
Pharma

GV-backed start­up Rani gets $53M from new in­vestors for 'ro­bot­ic pil­l'

8 years ago
Financing

In lat­est blow to Te­va, CGRP mi­graine med could be de­layed while ri­vals race to­wards the fin­ish line

8 years ago
Pharma

Case West­ern/Sang­amo get $11M grant to wipe out HIV; Sage's de­pres­sion drug, GSK's vac­cine get break­through ther­a­py ...

8 years ago
News Briefing

Ve­rastem takes Ab­b­Vie’s blood can­cer castoff to the FDA

8 years ago
Pharma

Tak­ing on lousy side ef­fects of ex­ist­ing meds, NEA-backed Xoc tack­les Parkin­son’s/mi­graines with $30M Se­ries A

8 years ago
Financing
Startups

Zo­genix wins in­side track at FDA with child­hood epilep­sy ‘break­through’

8 years ago
Pharma

Roche hails an­oth­er PhI­II win on Tecen­triq com­bo, re­ports promis­ing kid­ney can­cer da­ta

8 years ago
R&D

Stock plum­mets at Eye­Gate fol­low­ing Phase IIb flop for cataract surgery

8 years ago
R&D

Bil­lion-dol­lar biosim mak­er mulls $500M Hong Kong IPO

8 years ago
Financing
China

Af­ter EMA flop, Puma takes Ner­l­ynx to Chi­na in new out-li­cens­ing deal

8 years ago
China
Pharma

Nu­clear scare to fu­el an­ti-ra­di­a­tion drug sales? PTx buys ex-Sanofi drug just in case

8 years ago
Pharma

NIH, Fox Foun­da­tion al­lies with bio­phar­mas on $24M Parkin­son's project; FDA ac­cepts Ther­a­vance/My­lan NDA for COPD ...

8 years ago
News Briefing

Start­up with Johns Hop­kins roots rais­ing $40.5 mil­lion to de­vel­op can­cer me­tab­o­lism drugs

8 years ago
Financing
Startups

Eye­ing a multi­bil­lion-dol­lar mar­ket, Shire snags pre­clin­i­cal IVIg ri­val from AB Bio­sciences

8 years ago
R&D
Pharma

Can­cer drug to treat dwarfism? Aban­doned No­var­tis as­set snagged by Bridge­Bio’s QED Ther­a­peu­tics

8 years ago
Startups

Sus­pi­cious re­turns trig­ger in­sid­er trad­ing suit fol­low­ing $11.6B Biover­a­tiv deal

8 years ago
Pharma

In post-IPO par­ty, Nas­daq’s new­com­ers Ar­mo, Men­lo and Sol­id soar with­in hours of list­ing

8 years ago
Financing
Pharma

Ex-Mer­ri­mack CEO Mul­roy launch­es on­col­o­gy start­up Part­ner Ther­a­peu­tics

8 years ago
Startups
Outsourcing

Men­lo bags $119M IPO on promise of ex-Mer­ck drug

8 years ago
Financing

GW on fire: PhI­II epilep­sy da­ta sig­nals suc­cess ahead for first CBD drug

8 years ago
R&D
First page Previous page 9101112131415 Next page Last page
A service from the Financial Times